Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity.
Dannenfelser R, Nome M, Tahiri A, Ursini-Siegel J, Vollan HKM, Haakensen VD, Helland Å, Naume B, Caldas C, Børresen-Dale AL, Kristensen VN, Troyanskaya OG. Dannenfelser R, et al. Among authors: nome m. Oncotarget. 2017 Jul 7;8(34):57121-57133. doi: 10.18632/oncotarget.19078. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915659 Free PMC article.
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab.
Jabeen S, Zucknick M, Nome M, Dannenfelser R, Fleischer T, Kumar S, Lüders T, von der Lippe Gythfeldt H, Troyanskaya O, Kyte JA, Børresen-Dale AL, Naume B, Tekpli X, Engebraaten O, Kristensen V. Jabeen S, et al. Among authors: nome m. Oncoimmunology. 2018 Aug 6;7(11):e1457598. doi: 10.1080/2162402X.2018.1457598. eCollection 2018. Oncoimmunology. 2018. PMID: 30377556 Free PMC article.
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers.
Nome ME, Euceda LR, Jabeen S, Debik J, Bathen TF, Giskeødegård GF, Taskén KA, Maelandsmo GM, Halvorsen B, Yndestad A, Borgen E, Garred Ø, Aukrust P, Ueland T, Engebraaten O, Kristensen VN, Tekpli X. Nome ME, et al. Int J Cancer. 2020 Jan 1;146(1):223-235. doi: 10.1002/ijc.32638. Epub 2019 Oct 8. Int J Cancer. 2020. PMID: 31444972 Free article. Clinical Trial.
A Comparative Study of Large Language Models, Human Experts, and Expert-Edited Large Language Models to Neuro-Ophthalmology Questions.
Tailor PD, Dalvin LA, Starr MR, Tajfirouz DA, Chodnicki KD, Brodsky MC, Mansukhani SA, Moss HE, Lai KE, Ko MW, Mackay DD, Di Nome MA, Dumitrascu OM, Pless ML, Eggenberger ER, Chen JJ. Tailor PD, et al. Among authors: di nome ma. J Neuroophthalmol. 2024 Apr 2. doi: 10.1097/WNO.0000000000002145. Online ahead of print. J Neuroophthalmol. 2024. PMID: 38564282
Ocular Neuromyotonia: Clinical Features, Diagnosis, and Outcomes.
Bodi TB, Klaehn LD, Kramer AM, Bhatti MT, Brodsky MC, Eggenberger ER, Di Nome MA, Leavitt JA, Garrity JA, Chen JJ, Mansukhani SA. Bodi TB, et al. Among authors: di nome ma. Am J Ophthalmol. 2024 Feb 16;263:61-69. doi: 10.1016/j.ajo.2024.02.003. Online ahead of print. Am J Ophthalmol. 2024. PMID: 38369222
Idiopathic Intracranial Hypertension and Visual Loss.
Di Nome MA. Di Nome MA. J Neuroophthalmol. 2024 Mar 1;44(1):e200. doi: 10.1097/WNO.0000000000002077. Epub 2023 Dec 20. J Neuroophthalmol. 2024. PMID: 38117561 No abstract available.
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.
Chen JJ, Flanagan EP, Pittock SJ, Stern NC, Tisavipat N, Bhatti MT, Chodnicki KD, Tajfirouz DA, Jamali S, Kunchok A, Eggenberger ER, Nome MAD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Moss HE, Navarro SEV, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Danesh-Meyer H, Ivanov S, Huda S, Forcadela M, Hodge D, Poullin P, Rode J, Papeix C, Saheb S, Boudot de la Motte M, Vignal C, Hacohen Y, Pique J, Maillart E, Deschamps R, Audoin B, Marignier R. Chen JJ, et al. Among authors: nome mad. Am J Ophthalmol. 2023 Aug;252:213-224. doi: 10.1016/j.ajo.2023.02.013. Epub 2023 Feb 21. Am J Ophthalmol. 2023. PMID: 36822570
Vision Rehabilitation Preferred Practice Pattern®.
Jackson ML, Virgili G, Shepherd JD, Di Nome MA, Fletcher DC, Kaleem MA, Lam LA, Lawrence LM, Sunness JS, Riddering AT; American Academy of Ophthalmology Preferred Practice Pattern Vision Rehabilitation Committee. Jackson ML, et al. Among authors: di nome ma. Ophthalmology. 2023 Mar;130(3):P271-P335. doi: 10.1016/j.ophtha.2022.10.033. Epub 2022 Dec 19. Ophthalmology. 2023. PMID: 36543605 No abstract available.
Details and outcomes of a large cohort of MOG-IgG associated optic neuritis.
Chen JJ, Flanagan EP, Bhatti MT, Tisavipat N, Jamali S, Kunchok A, Eggenberger ER, Nome MD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Seleme N, Mejia-Vergara AJ, Moss HE, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Hellmann MA, Vuppala A, Hodge D, Pittock SJ. Chen JJ, et al. Among authors: nome md. Mult Scler Relat Disord. 2022 Dec;68:104237. doi: 10.1016/j.msard.2022.104237. Epub 2022 Oct 10. Mult Scler Relat Disord. 2022. PMID: 36252317
15 results